Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.2B | 3.0B | 3.0B | 2.9B |
| Cost of revenue | 1.5B | 1.4B | 1.4B | 1.3B |
| Gross profit | 1.8B | 1.6B | 1.7B | 1.6B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 137M | 137M | 124M | 168M |
| Other operating expenses | — | — | — | — |
| Operating income | 1.3B | 1.1B | 1.1B | 1.1B |
| Non operating interest income | ||||
| Income | 33M | 36M | 39M | 36M |
| Expense | 206M | 213M | 223M | 233M |
| Other income expense | -13M | -11M | -58M | -23M |
| Pretax income | 1.1B | 905M | 898M | 861M |
| Tax provision | 255M | 196M | 227M | 222M |
| Net income | 812M | 709M | 671M | 639M |
| Basic EPS | 1.4 | 1.2 | 1.2 | 1.1 |
| Diluted EPS | 1.4 | 1.2 | 1.1 | 1.1 |
| Basic average shares | 574M | 574M | 574M | 573M |
| Diluted average shares | 577M | 577M | 577M | 575M |
| EBITDA | 1.7B | 1.5B | 1.5B | 1.5B |
| Net income from continuing op. | 812M | 709M | 671M | 639M |
| Minority interests | -15M | -11M | -14M | -7M |
| Preferred stock dividends | — | — | — | — |